Real Estate

CanalSide Food + Drink at CambridgeSide opens

CanalSide Food + Drink at CambridgeSide opens

Opening October 25th, CanalSide Food + Drink at CambridgeSide, is a new food experience offering local fare with global flair. CanalSide offers visitors waterfront views, a collection of eateries, and a centrally located bar. C-Side Bar, situated in the center of CanalSide, presents a selection of craft cocktails, beer, and wine available to pair with […]

Read more
Massachusetts landlords face lawsuits over pricing algorithm

Massachusetts landlords face lawsuits over pricing algorithm

By Jim Morrison The US Justice Department and attorneys general in eight states are suing a popular AI-enabled property management software system over alleged anti-trust violations. The Justice Department — and the states of North Carolina, California, Colorado, Connecticut, Minnesota, Oregon, Tennessee, and Washington — accuse RealPage Inc. of violating the Sherman Act and harming “millions […]

Read more
Simon Moves To Give Up Philadelphia Mall, Canceled Deal Could Signal Fatigue, Relocation Plans Spell Trouble for DC Office Loan

Simon Moves To Give Up Philadelphia Mall, Canceled Deal Could Signal Fatigue, Relocation Plans Spell Trouble for DC Office Loan

By Mark Heschmeyer Simon Moves To Give Up Philadelphia Mall: Retail real estate investment trust Simon Property Group is working with lenders to turn the title over to its 1.21 million-square-foot Philadelphia Mills Mall rather than pay off debt that was set to come due this month. The property backs $103.7 million in outstanding commercial mortgage-backed securities debt spread […]

Read more
HubSpot stock sinks as Alphabet reportedly sours on acquisition

HubSpot stock sinks as Alphabet reportedly sours on acquisition

By Lucia Maffei Shares of HubSpot Inc. plunged in Wednesday afternoon trading after Bloomberg reported that Google parent company Alphabet put the brakes on its rumored acquisition of the Cambridge-based marketing firm. On Wednesday HubSpot’s stock (NYSE: HUBS) closed down 12.22%, giving the company a market capitalization of $25.06 billion. When rumors of a potential deal first emerged in April, the markets were valuing […]

Read more
Eli Lilly buys Waltham biotech for $3.2B

Eli Lilly buys Waltham biotech for $3.2B

By Hannah Green  Eli Lilly and Co. is buying a Waltham biotech in a deal valued at around $3.2 billion.  The startup being acquired is Morphic Holding Inc. (NASDAQ: MORF), a Waltham company working on treatments for chronic diseases such as types of inflammatory bowel disease. Indianapolis-based Lilly (NYSE: LLY) plans to acquire all outstanding shares of […]

Read more

Compare